Evidence map›Paper›PMID 36216029›Full record

ArticleNeuropharmacology2022

Corticotropin releasing factor in the nucleus basalis of Meynert impairs attentional performance and reduces levels of glutamate and taurine in male and female rats.

Samantha R Eck, Nikolaos Kokras, Brittany Wicks, Petros Baltimas, Arron Hall, Nina van Bendegem, Madeleine Salvatore, Sarah R Cohen, Joy Bergmann, Attilio Ceretti and 3 more

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Samantha R EckDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Nikolaos KokrasDepartment of Pharmacology, Medical School, National and Kapodistrian University of Athens, Mikras Asias 75, 11527, Goudi, Athens, Greece; First Department of Psychiatry, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Brittany WicksDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Petros BaltimasDepartment of Pharmacology, Medical School, National and Kapodistrian University of Athens, Mikras Asias 75, 11527, Goudi, Athens, Greece.
Arron HallDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Nina van BendegemDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Madeleine SalvatoreDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Sarah R CohenDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Joy BergmannDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Attilio CerettiDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Vinay ParikhDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA.
Christina DallaDepartment of Pharmacology, Medical School, National and Kapodistrian University of Athens, Mikras Asias 75, 11527, Goudi, Athens, Greece.
Debra A BangasserDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA 19122, USA; Neuroscience Institute, Georgia State University, Atlanta, GA 30303, USA. Electronic address: dbangasser@gsu.edu.
Temple University · US

Funding

TRAINING PROGRAM: DRUGS OF ABUSE RELATED NEUROPEPTIDEST32DA007237 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLEN M UNTERWALD · 1988 to 2026
$10.6M
Delineating the epigenetic and neural mechanisms by which early life scarcity alters motivated behaviorR01DA056534 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Debra A Bangasser, Mathieu Wimmer · 2022 to 2026
$3.2M
Sex Differences In Stress Inoculation Of Addiction-Like PhenotypesR01DA049837 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI BANGASSER, DEBRA A · 2020 to 2024
$3.1M
NIDA NIH HHS R01 DA049837NIDA NIH HHS R01 DA056534NIDA NIH HHS T32 DA007237
6 · The paper itself

Abstract

Psychiatric disorders that are characterized by impairments in sustained attention, including attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), and major depression are also sensitive to exacerbation by stress. Sustained attention relies on cholinergic and non-cholinergic projections from the nucleus basalis of Meynert (NBM) in the basal forebrain to the medial prefrontal cortex (mPFC). We have previously shown that central administration of the stress neuropeptide corticotropin releasing factor (CRF) impairs performance on the sustained attention task (SAT) in adult male and female rats. The present study investigated whether this effect was mediated by CRF's action in the NBM. Rats were administered CRF in the NBM and subsequent SAT performance was measured. A high dose of CRF (100 ng) significantly impaired performance on non-signaled events across sex. Because performance on non-signaled events is believed to depend on non-cholinergic (i.e., GABA and glutamate) signaling, high performance liquid chromatography was used to quantify amino acid levels in the NBM and mPFC. We found females have higher levels of glutamate, glutamine, GABA glycine, and alanine in the NBM than males. Importantly, CRF in the NBM led to a local decrease of taurine and several amino acids involved in glutamate synthesis in males and females, changes which may mediate the CRF-induced SAT performance deficit. Together these studies suggest that CRF regulation of amino acids in the NMB contributes to stress-induced attention deficits.

Indexed as

Basal Nucleus of MeynertCorticotropin-Releasing HormoneAnimalsFemalegamma-Aminobutyric AcidGlutamic AcidMaleRatsTaurineCorticotropin-Releasing Hormonegamma-Aminobutyric AcidGlutamic AcidTaurineAttentionBasal forebrainCognitionGlutamateStress

Identifiers

PMID36216029
PMCPMC9883789
OpenAlexW4303520952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.